001: The Business Of Biotech: Allan Shaw
Business Of Biotech
00:00
How to Mitigate the Risk Associated With CMC Considerations for First in Human Studies
When it comes to CMC considerations for first in human studies, you know, you've been there. What happens to a first time bio pharma CEOs blood pressure around the risk associated with CMC considerations? And how do they mitigate that risk? Well, I guess depending on the upfront talks that will reduce some of your anxiety,. If there's a history of monkey fatalities or that's going to be a little bit more anxious and would question the wisdom of moving forward.
Play episode from 32:41
Transcript
